Skip to content

Clinical Study of Shugan Tiaoshen (Soothing the Liver and Regulating Mind) Needling Treat Mild Depression Onset Time: a Randomized Controlled Trial

Clinical Study of Shugan Tiaoshen (Soothing the Liver and Regulating Mind) Needling Treat Mild Depression Onset Time: a Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003179
Enrollment
Unknown
Registered
2020-04-05
Start date
2020-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Depression

Interventions

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of ICD-10 depressive episode; In the patients with mild depressive episode, the score of HAMD-17 scale was 8 > and <= 17. (2) Aged 18 to 55 years; (3) have no previous history of serious organic brain diseases and physical diseases, can understand the contents of the scale and cooperate with the treatment; (4) no previous history of mental illness; (5) right-handed; (6) Do not drink caffeinated beverages, do not drink alcohol, do not smoke during the intervention; (7) Voluntary participation in clinical research and consent to sign informed consent.

Exclusion criteria

Exclusion criteria: (1) organic mental disorders, or depression related to psychoactive and non-addictive substances; (2) Have other family history of mental illness such as: dementia, schizophrenia, mania, addiction, etc.; (3) those who cannot understand the contents of the scale and cannot evaluate the efficacy; (4) do not cooperate with the treatment plan or fear acupuncture.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Secondary

MeasureTime frame
Patient subjective efficacy evaluation;BDI-13;Evaluation of acupuncture expectation;

Countries

China

Contacts

Public ContactWenbin Fu

Department of Acupuncture and Moxibustion, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)

fuwenbin@139.com+86 13808888626

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026